| Identification | Back Directory | [Name]
Efaproxiral sodium | [CAS]
170787-99-2 | [Synonyms]
RSR-13
Rsr 13 sodium
Unii-3L83qp52xi
EFAPROXIRAL SODIUM
Efaproxiral Sodium (RSR13)
Efaproxiral (sodiuM salt forM)
2-[4-[2-(3,5-Dimethylphenylamino)-2-oxoethyl]phenoxy]-2-methylpropionic acid
Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate
2-[4-[2-[(3,5-Dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoic Acid Sodium Salt
2-(4-(2-((3,5-Dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt
Propanoic acid, 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methyl-, monosodium salt | [EINECS(EC#)]
811-228-2 | [Molecular Formula]
C20H22NNaO4 | [MDL Number]
MFCD02093864 | [MOL File]
170787-99-2.mol | [Molecular Weight]
363.383 |
| Chemical Properties | Back Directory | [Melting point ]
240.0
~244.0
°C | [storage temp. ]
Store at -20°C | [solubility ]
≥12.83 mg/mL in H2O with ultrasonic; ≥18.4 mg/mL in DMSO; ≥18.45 mg/mL in EtOH | [form ]
powder to lump | [color ]
White to Almost white |
| Hazard Information | Back Directory | [Uses]
Treatment of clinical conditions characterized by tissue hypoxia including cardiovascular, surgical, and critical care conditions; adjunctive treatment in standard radiation therapy and chemotherapy (synthetic allosteric modifier of hemoglobin. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
m.is0513.com/ShowSupplierProductsList15748/0.htm |
|